Effect of Dapagliflozine on Systemic and Renal Endothelial Function

Clinical trial NCT02501616 · UNKNOWN

Trial details

NCT number: NCT02501616
Sponsor: Seoul National University Hospital
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Endothelial Function Type 2 Diabetes

Start date: 2014-12-01
Primary completion: 2015-12-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.